Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) - Part I: In Vitro Testing and Characterization.
Mohammad A M MominDale FarkasMichael HindleFelicia HallRobert M DiBlasiPhilip Worth LongestPublished in: Pharmaceutical research (2024)
A high-efficiency aerosol SLS product was designed and tested that may enable an order of magnitude reduction in administered phospholipid dose, and provide rapid aerosol administration to infants with RDS.